Recruiting
Phase 2

Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD

Sponsor:

Boston University

Code:

NCT04468360

Conditions

Post Traumatic Stress Disorder

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

3-day differential fear conditioning, extinction, and extinction retention testing paradigm

Allopregnanolone (Allo) with Dexolve in 0.9% saline for injection manufactured by University of California, Davis

Matching IV Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information